Related Experiment Video
Updated: Oct 3, 2025

A Novel Method for the Culture and Polarized Stimulation of Human Intestinal Mucosa Explants
Published on: May 1, 2013
Intraspecific Diversity of Microbial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii
Sandrine Auger1, Camille Kropp1, Esther Borras-Nogues1
1Université Paris-Saclay, INRAE, AgroParisTech, Micalis, 78352 Jouy-en-Josas, France.
Abstract:
The commensal bacterium Faecalibacterium prausnitzii has unique anti-inflammatory properties, at least some of which have been attributed to its production of MAM, the Microbial Anti-inflammatory Molecule. Previous phylogenetic studies of F. prausnitzii strains have revealed the existence of various phylogroups. In this work, we address the question of whether MAMs from different phylogroups display distinct anti-inflammatory properties. We first performed wide-scale identification, classification, and phylogenetic analysis of MAM-like proteins encoded in different genomes of F. prausnitzii. When combined with a gene context analysis, this approach distinguished at least 10 distinct clusters of MAMs, providing evidence for functional diversity within this protein. We then selected 11 MAMs from various clusters and evaluated their anti-inflammatory capacities in vitro. A wide range of anti-inflammatory activity was detected. MAM from the M21/2 strain had the highest inhibitory effect (96% inhibition), while MAM from reference strain A2-165 demonstrated only 56% inhibition, and MAM from strain CNCM4541 was almost inactive. These results were confirmed in vivo in murine models of acute and chronic colitis. This study provides insights into the family of MAM proteins and generates clues regarding the choice of F. prausnitzii strains as probiotics for use in targeting chronic inflammatory diseases.
Insights
Microbial Anti-inflammatory Molecules (MAMs) from different Faecalibacterium prausnitzii strains show varied anti-inflammatory effects. This discovery aids in selecting F. prausnitzii strains for treating inflammatory diseases.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Faecalibacterium prausnitzii, a gut commensal, possesses anti-inflammatory properties.
- These properties are partly attributed to its production of Microbial Anti-inflammatory Molecules (MAMs).
- Previous research identified distinct phylogroups within F. prausnitzii strains.
Purpose of the Study:
- To investigate whether MAMs from different F. prausnitzii phylogroups exhibit varying anti-inflammatory activities.
- To explore the functional diversity within the family of MAM proteins.
- To identify potential F. prausnitzii strains for probiotic applications in inflammatory diseases.
Main Methods:
- Phylogenetic analysis of MAM-like proteins across various F. prausnitzii genomes.
- Gene context analysis to classify MAMs into distinct clusters.
- In vitro and in vivo (murine colitis models) evaluation of anti-inflammatory capacities of selected MAMs.
Main Results:
- Identification of at least 10 distinct clusters of MAMs, suggesting functional diversity.
- Significant variation in anti-inflammatory activity among tested MAMs, with one showing 96% inhibition and others much less.
- In vivo confirmation of differential anti-inflammatory effects in murine models of colitis.
Conclusions:
- MAMs produced by different F. prausnitzii phylogroups possess distinct anti-inflammatory potencies.
- The study highlights the functional diversity within the MAM protein family.
- Findings provide crucial insights for selecting specific F. prausnitzii strains as probiotics for managing chronic inflammatory conditions.
Related Concept Videos
Bacterial Phylum Firmicutes
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
What is Monogastric Digestion?
Bacterial Phylum Actinobacteria
Gene Regulation in Microbial Communities: Quorum Sensing

